LakeShore Biopharma Co., Ltd (LSBCF) is a Healthcare · Biotechnology company listed on NYSE. Price $0.07 (+0.00%), Market cap $0.00B, 52-week low–high $0.03 ~ $1.38.
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic
Financial statements, price targets, institutional (13F) holdings and related news for LakeShore Biopharma Co., Ltd are updated in real time on BlackAll Trade.
LakeShore Biopharma Co., Ltd trades at $0.07 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
LakeShore Biopharma Co., Ltd has a market cap of about $0.00B.
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its produ